Your browser doesn't support javascript.
loading
Pembrolizumab in HER2-Positive Gastric Cancer.
Janjigian, Yelena Y; Kawazoe, Akihito; Bai, Yuxian; Xu, Jianming; Lonardi, Sara; Metges, Jean Phillipe; Yañez, Patricio; Wyrwicz, Lucjan S; Shen, Lin; Ostapenko, Yuriy; Bilici, Mehmet; Chung, Hyun Cheol; Shitara, Kohei; Qin, Shukui; Van Cutsem, Eric; Tabernero, Josep; Luo, Suxia; Mahave, Mauricio; Tang, Yong; Lowery, Maeve; Monteiro, Maria M F; Xu, Linzhi; Shih, Chie-Schin; Sharan, Kanu P; Bhagia, Pooja; Rha, Sun Young.
Afiliação
  • Janjigian YY; Memorial Sloan Kettering Cancer Center, New York, NY janjigiy@mskcc.org.
  • Kawazoe A; National Cancer Hospital East, Kashiwa, Japan.
  • Bai Y; Harbin Medical University Cancer Hospital, Harbin, China.
  • Xu J; Fifth Medical Center of the People's Liberation Army, Beijing, China.
  • Lonardi S; Istituto Oncologico Veneto, Padua, Italy.
  • Metges JP; University Hospital of Brest, Brest, France.
  • Yañez P; James Lind Cancer Research Center, Temuco, Chile.
  • Wyrwicz LS; Maria Sklodowska-Curie National Cancer Research Institute, Warsaw, Poland.
  • Shen L; Key Laboratory of Carcinogenesis and Translational Research, Beijing, China.
  • Ostapenko Y; National Cancer Institute, Kyiv, Ukraine.
  • Bilici M; Atatürk University, Erzurum, Turkey.
  • Chung HC; Yonsei Cancer Center, Seoul, South Korea.
  • Shitara K; National Cancer Hospital East, Kashiwa, Japan.
  • Qin S; Cancer Center of the People's Liberation Army, Nanjing, China.
  • Van Cutsem E; University Hospitals Gasthuisberg, Leuven, Belgium.
  • Tabernero J; Vall d'Hebron University Hospital Institute of Oncology, Barcelona, Spain.
  • Luo S; Henan Cancer Hospital, Zhengzhou, China.
  • Mahave M; Fundación Arturo López Pérez, Santiago, Chile.
  • Tang Y; Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi, China.
  • Lowery M; Trinity St. James's Cancer Institute, Dublin, Ireland.
  • Monteiro MMF; Instituto do Câncer do Ceará, Ceará, Brazil.
  • Xu L; Merck, Rahway, NJ.
  • Shih CS; Merck, Rahway, NJ.
  • Sharan KP; Merck, Rahway, NJ.
  • Bhagia P; Merck, Rahway, NJ.
  • Rha SY; Yonsei Cancer Center, Seoul, South Korea.
N Engl J Med ; 391(14): 1360-1362, 2024 Oct 10.
Article em En | MEDLINE | ID: mdl-39282917
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Receptor ErbB-2 / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Receptor ErbB-2 / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article